Related references
Note: Only part of the references are listed.The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma
Karen L. Talia et al.
PATHOLOGY (2023)
The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance
Adan Arizmendi-Izazaga et al.
BIOCHIMIE (2023)
Biomarker-driven therapy in endometrial cancer
Hannah Karpel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
Yen My Vuu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Eliminating oncogenic RAS: back to the future at the drawing board
Candy Laura Steffen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2023)
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Yike Jiang et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A
Hung-Yu Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
Yannan Qin et al.
CANCER CELL INTERNATIONAL (2022)
Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to MECP2 Gain- and Loss-of-Function Involves MeCP2 Isoform-Specific Homeostasis in the Brain
Marjorie Buist et al.
CELLS (2022)
The Chromatin Structure at the MECP2 Gene and In Silico Prediction of Potential Coding and Non-Coding MECP2 Splice Variants
Danilo Shevkoplyas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
MeCP2 and transcriptional control of eukaryotic gene expression
Ghanan Bin Akhtar et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2022)
Clinicopathological Characteristics of Advanced Epstein-Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression
Hyeonguk Jang et al.
ANTICANCER RESEARCH (2022)
circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324
Hanqin Weng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
Katrina V. Good et al.
FRONTIERS IN GENETICS (2021)
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Shervin Pejhan et al.
BIOMOLECULES (2021)
Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas
B. Lhermitte et al.
NEUROCHIRURGIE (2021)
Therapeutic Targeting of Cancer: Epigenetic Homeostasis
Xiaoyuan Yu et al.
FRONTIERS IN ONCOLOGY (2021)
LINC00518 Promotes Cell Proliferation by Regulating the Cell Cycle of Lung Adenocarcinoma Through miR-185-3p Targeting MECP2
Xu Han et al.
FRONTIERS IN ONCOLOGY (2021)
Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6-methyladenosine methylation through methyltransferase-like 14
Shuo Wang et al.
CANCER SCIENCE (2021)
MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway
Lumin Wang et al.
MOLECULAR ONCOLOGY (2021)
Navigating the DNA methylation landscape of cancer
Atsuya Nishiyama et al.
TRENDS IN GENETICS (2021)
Editorial: Epigenetic Mechanisms and Their Involvement in Rare Diseases
Mojgan Rastegar et al.
FRONTIERS IN GENETICS (2021)
Remodeling the Epigenetic Landscape of Cancer-Application Potential of Flavonoids in the Prevention and Treatment of Cancer
Weiyi Jiang et al.
FRONTIERS IN ONCOLOGY (2021)
Transcriptional Regulation of MECP2E1-E2 Isoforms and BDNF by Metformin and Simvastatin through Analyzing Nascent RNA Synthesis in a Human Brain Cell Line
Marjorie Buist et al.
BIOMOLECULES (2021)
A History of Cancer Research: Tumor Suppressor Genes
Joseph Lipsick
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription
DongDong Tong et al.
ONCOGENESIS (2020)
Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2
Qian Zhou et al.
MOLECULAR ONCOLOGY (2020)
MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription
Dan Luo et al.
CANCERS (2020)
MeCP2 inhibits proliferation and migration of breast cancer via suppression of epithelial-mesenchymal transition
Wei Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets
Jerry Vriend et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial-mesenchymal transition in pancreatic cancer cells
Huizhi Wang et al.
ONCOGENESIS (2020)
The MeCP2E1/E2-BDNF-miR132Homeostasis Regulatory Network Is Region-Dependent in the Human Brain and Is Impaired in Rett Syndrome Patients
Shervin Pejhan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Identification of Novel MeCP2 Cancer-Associated Target Genes and Post-Translational Modifications
Isabel Castro-Piedras et al.
FRONTIERS IN ONCOLOGY (2020)
MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine
Dongdong Tong et al.
ONCOGENESIS (2020)
DNA Methylation Contributes to the Differential Expression Levels of Mecp2 in Male Mice Neurons and Astrocytes
Vichithra R. B. Liyanage et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
1 Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates
Kimia Sheikholeslami et al.
CANCERS (2019)
DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2019)
A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma
Erbao Bian et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Genome-Wide Transcriptome Landscape of Embryonic Brain-Derived Neural Stem Cells Exposed to Alcohol with Strain-Specific Cross-Examination in BL6 and CD1 Mice
Wayne Xu et al.
SCIENTIFIC REPORTS (2019)
DNA Methyltransferases, DNA Methylation, and Age-Associated Cognitive Function
Di Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
MeCP2 overexpression inhibits proliferation, migration and invasion of C6 glioma by modulating ERK signaling and gene expression
Kedarlal Sharma et al.
NEUROSCIENCE LETTERS (2018)
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
Eric Hervouet et al.
CLINICAL EPIGENETICS (2018)
MECP2 Mutation Interrupts Nucleolin-mTOR-P70S6K Signaling in Rett Syndrome Patients
Carl O. Olson et al.
FRONTIERS IN GENETICS (2018)
Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer
Jaeseob Lee et al.
PROSTATE (2017)
MECP2 expression in gastric cancer and its correlation with clinical pathological parameters
Jing Zhang et al.
MEDICINE (2017)
DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review)
Maria Nowacka-Zawisza et al.
ONCOLOGY REPORTS (2017)
Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met
Tao Chen et al.
SCIENTIFIC REPORTS (2017)
MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1
L. Y. Zhao et al.
ONCOGENESIS (2017)
MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways
Lingyu Zhao et al.
EBIOMEDICINE (2017)
NeuroEpigenetics and Neurodevelopmental Disorders: From Molecular Mechanisms to Cell Fate Commitments of the Brain Cells and Human Disease
Mojgan Rastegar
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate
Somnath Pandey et al.
BIOCHEMISTRY AND CELL BIOLOGY (2017)
Overview of the Genetic Basis and Epigenetic Mechanisms that Contribute to FASD Pathobiology
Vichithra R. B. Liyanage et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability
Laura Bianciardi et al.
JOURNAL OF HUMAN GENETICS (2016)
Lentivirus-mediated knockdown of MeCP2 inhibits the growth of colorectal cancer cells in vitro
Ning Song et al.
MOLECULAR MEDICINE REPORTS (2016)
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
Manish Neupane et al.
CANCER DISCOVERY (2016)
DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac
Yafang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect
Dongdong Tong et al.
ONCOTARGET (2016)
MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells
Min Xu et al.
ONCOTARGET (2016)
Ethanol deregulates Mecp2/MeCP2 in differentiating neural stem cells via interplay between 5-methylcytosine and 5-hydroxymethylcytosine at the Mecp2 regulatory elements
Vichithra Rasangi Batuwita Liyanage et al.
EXPERIMENTAL NEUROLOGY (2015)
Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells
Xiaoqin Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome
Dag H. Yasui et al.
HUMAN MOLECULAR GENETICS (2014)
Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements
Carl O. Olson et al.
PLOS ONE (2014)
Epigenetic regulation in cancer progression
Eva Baxter et al.
CELL AND BIOSCIENCE (2014)
DNA methyltransferases: a novel target for prevention and therapy
Dharmalingam Subramaniam et al.
FRONTIERS IN ONCOLOGY (2014)
Rett syndrome with colon cancer presented with sigmoid volvulus: Report of a case
Tonguc Utku Yilmaz et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2014)
Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons
Yun Li et al.
CELL STEM CELL (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells
Vichithra R. B. Liyanage et al.
MOLECULAR AUTISM (2013)
Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1
Somasish Ghosh Dastidar et al.
JOURNAL OF NEUROSCIENCE (2012)
p53 Binds to Estrogen Receptor 1 Promoter in Human Breast Cancer Cells
Mozhgan Rasti et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
Robby Mathew Zachariah et al.
NEURAL PLASTICITY (2012)
The Genetic and Epigenetic Journey of Embryonic Stem Cells into Mature Neural Cells
Brendan M. Olynik et al.
Frontiers in Genetics (2012)
Epigenetic control of Hox genes during neurogenesis, development, and disease
Benjamin A. Barber et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Functional Switching of TGF-β1 Signaling in Liver Cancer via Epigenetic Modulation of a Single CpG Site in TTP Promoter
Bo Hwa Sohn et al.
GASTROENTEROLOGY (2010)
Gene amplification as double minutes or homogeneously staining regions in solid tumors: Origin and structure
Clelia Tiziana Storlazzi et al.
GENOME RESEARCH (2010)
miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer
Rie Wada et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Our changing view of the genomic landscape of cancer
Daphne W. Bell
JOURNAL OF PATHOLOGY (2010)
A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition
Georgios Pampalakis et al.
CANCER RESEARCH (2009)
Methylation-Mediated Repression of GADD45α in Prostate Cancer and Its Role as a Potential Therapeutic Target
Kavitha Ramachandran et al.
CANCER RESEARCH (2009)
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
Jaclyn A. Freudenberg et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Epigenetic Control
Genevieve P. Delcuve et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines
Mario Dandrea et al.
NUCLEIC ACIDS RESEARCH (2009)
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Mojgan Rastegar et al.
PLOS ONE (2009)
MeCP2, a key contributor to neurological disease, activates and represses transcription
Maria Chahrour et al.
SCIENCE (2008)
Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors
S. M. Pulukuri et al.
ONCOGENE (2007)
Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer
Ruo-Kai Lin et al.
LUNG CANCER (2007)
Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers
Jairo Rodriguez et al.
CANCER RESEARCH (2006)
The methyl-CpG- binding protein MECP2 is required for prostate cancer cell growth
D Bernard et al.
ONCOGENE (2006)
Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor α (ER) promoter upon reactivation in ER-negative human breast cancer cells
D Sharma et al.
MOLECULAR ENDOCRINOLOGY (2005)
The major form of MeCP2 has a novel N-terminus generated by alternative splicing
S Kriaucionis et al.
NUCLEIC ACIDS RESEARCH (2004)
Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications
C Osborne et al.
ONCOLOGIST (2004)
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
E Ballestar et al.
EMBO JOURNAL (2003)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
HM Müller et al.
BRITISH JOURNAL OF CANCER (2003)
MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma
A Darwanto et al.
CANCER SCIENCE (2003)
β2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3,-8 and-9 pathways but through increased reactive oxygen species
J Gordon et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant
CH Wu et al.
ONCOGENE (2002)
β2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein
CH Wu et al.
ONCOGENE (2001)
DNA methylation: An alternative pathway to cancer
SA Wajed et al.
ANNALS OF SURGERY (2001)
Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
V Santini et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
